ID: ALA4760943

Max Phase: Preclinical

Molecular Formula: C23H30N2OS

Molecular Weight: 382.57

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCCc1cc2nc3ccc(N(C)C)cc3sc-2cc1=O

Standard InChI:  InChI=1S/C23H30N2OS/c1-4-5-6-7-8-9-10-11-17-14-20-23(16-21(17)26)27-22-15-18(25(2)3)12-13-19(22)24-20/h12-16H,4-11H2,1-3H3

Standard InChI Key:  CJCZBBASBWBIEC-UHFFFAOYSA-N

Associated Targets(Human)

Lymphocyte 105 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 382.57Molecular Weight (Monoisotopic): 382.2079AlogP: 6.12#Rotatable Bonds: 9
Polar Surface Area: 33.20Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 3.11CX LogP: 6.61CX LogD: 6.61
Aromatic Rings: 1Heavy Atoms: 27QED Weighted: 0.33Np Likeness Score: -0.84

References

1. Liu J,Bandyopadhyay I,Zheng L,Khdour OM,Hecht SM.  (2020)  Antiferroptotic Activity of Phenothiazine Analogues: A Novel Therapeutic Strategy for Oxidative Stress Related Disease.,  11  (11): [PMID:33214825] [10.1021/acsmedchemlett.0c00293]

Source